PAVmed (PAVM) Shares Outstanding (Weighted Average) (2015 - 2025)

PAVmed's Shares Outstanding (Weighted Average) history runs 11 years deep, the most recent figure standing at $670466.0 for Q4 2025.

• In Q4 2025, Shares Outstanding (Weighted Average) rose 107.96% year-over-year to $670466.0; the TTM figure through Dec 2025 stood at $670466.0 (up 107.96% YoY), while the FY2025 annual figure was $670466.0, up 107.96% from the prior year.
• Shares Outstanding (Weighted Average) was $670466.0 for Q4 2025 at PAVmed, down from $21.6 million in the prior quarter.
• In the past five years, Shares Outstanding (Weighted Average) ranged from a high of $89.8 million in Q3 2022 to a low of $322407.0 in Q4 2024.
• Historically, Shares Outstanding (Weighted Average) has averaged $35.6 million across 5 years, with a median of $13.9 million in 2025.
• The sharpest annual moves came in 2024 and 2025: Shares Outstanding (Weighted Average) slumped 95.54% in 2024, then jumped 107.96% in 2025.
• A 5-year view of Shares Outstanding (Weighted Average) shows it stood at $77.5 million in 2021, then sank by 92.34% to $5.9 million in 2022, then rose by 21.78% to $7.2 million in 2023, then plunged by 95.54% to $322407.0 in 2024, then surged by 107.96% to $670466.0 in 2025.
• The last three Shares Outstanding (Weighted Average) figures came in at $670466.0 (Q4 2025), $21.6 million (Q3 2025), and $16.0 million (Q2 2025), per Business Quant data.